Acute cellular rejection and humoral sensitization in lung transplant recipients

Seminars in Respiratory and Critical Care Medicine

Volumn 31, Issue 2, 2010, Pages 179-188

  Martinu, Tereza ^a   Howell, David N ^a   Palmer, Scott M ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Acute rejection; Antibody mediated rejection; Humoral rejection; Lung transplantation

Indexed keywords

ALEMTUZUMAB; CYCLOSPORIN; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 2 RECEPTOR ANTIBODY; METHYLPREDNISOLONE; RITUXIMAB; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY;

ACUTE GRAFT REJECTION; CELL INFILTRATION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; GRAFT RECIPIENT; HISTOPATHOLOGY; HUMAN; HUMORAL IMMUNITY; KIDNEY GRAFT REJECTION; LUNG BIOPSY; LUNG GRAFT REJECTION; LUNG LAVAGE; LUNG TRANSPLANTATION; LYMPH NODE IRRADIATION; PATHOGENESIS; PLASMAPHERESIS; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PUVA; REVIEW; SENSITIZATION;

AGE FACTORS; GRAFT REJECTION; HUMANS; IMMUNITY, CELLULAR; IMMUNITY, HUMORAL; LUNG TRANSPLANTATION; TISSUE DONORS;

EID: 77950545058     PISSN: 10693424     EISSN: 10989048     Source Type: Journal    
DOI: 10.1055/s-0030-1249113     Document Type: Review

References (69)

1. Trulock E P., Christie J D., Edwards L B. et al. Registry of the International Society for Heart and Lung Transplantation: twenty-fourth official adult lung and heart-lung transplantation report-2007. J Heart Lung Transplant 2007 26 782-795
2. Sharples L D., McNeil K, Stewart S, Wallwork J. Risk factors for bronchiolitis obliterans: a systematic review of recent publications. J Heart Lung Transplant 2002 21 271-281
3. Snyder L D., Palmer S M. Immune mechanisms of lung allograft rejection. Semin Respir Crit Care Med 2006 27 534-543
4. Colvin R B., Smith R N. Antibody-mediated organ-allograft rejection. Nat Rev Immunol 2005 5 807-817
5. De Vito Dabbs A, Hoffman L A., Iacono A T., Zullo T G., McCurry K R., Dauber J H. Are symptom reports useful for differentiating between acute rejection and pulmonary infection after lung transplantation? Heart Lung 2004 33 372-380
6. Van Muylem A, Mülot C, Antoine M, Knoop C, Estenne M. Role of pulmonary function in the detection of allograft dysfunction after heart-lung transplantation. Thorax 1997 52 643-647
7. Gotway M B., Dawn S K., Sellami D et al. Acute rejection following lung transplantation: limitations in accuracy of thin-section CT for diagnosis. Radiology 2001 221 207-212
8. Shitrit D, Izbicki G, Fink G et al. Late postoperative pleural effusion following lung transplantation: characteristics and clinical implications. Eur J Cardiothorac Surg 2003 23 494-496
9. Stewart S, Fishbein M C., Snell G I. et al. Revision of the 1996 working formulation for the standardization of nomenclature in the diagnosis of lung rejection. J Heart Lung Transplant 2007 26 1229-1242 (Pubitemid 350256994)
10. Hopkins P M., Aboyoun C L., Chhajed P N. et al. Prospective analysis of 1,235 transbronchial lung biopsies in lung transplant recipients. J Heart Lung Transplant 2002 21 1062-1067
11. Trulock E P., Ettinger N A., Brunt E M., Pasque M K., Kaiser L R., Cooper J D. The role of transbronchial lung biopsy in the treatment of lung transplant recipients: an analysis of 200 consecutive procedures. Chest 1992 102 1049-1054
12. Chakinala M M., Ritter J, Gage B F. et al. Yield of surveillance bronchoscopy for acute rejection and lymphocytic bronchitis/bronchiolitis after lung transplantation. J Heart Lung Transplant 2004 23 1396-1404
13. Reynaud-Gaubert M, Thomas P, Gregoire R et al. Clinical utility of bronchoalveolar lavage cell phenotype analyses in the postoperative monitoring of lung transplant recipients. Eur J Cardiothorac Surg 2002 21 60-66
14. De Soyza A, Fisher A J., Small T, Corris P A. Inhaled corticosteroids and the treatment of lymphocytic bronchiolitis following lung transplantation. Am J Respir Crit Care Med 2001 164 1209-1212
15. Silkoff P E., Caramori M, Tremblay L et al. Exhaled nitric oxide in human lung transplantation: a noninvasive marker of acute rejection. Am J Respir Crit Care Med 1998 157 (6 Pt 1) 1822-1828
16. Kowalski R J., Post D R., Mannon R B. et al. Assessing relative risks of infection and rejection: a meta-analysis using an immune function assay. Transplantation 2006 82 663-668
17. Bhorade S M., Janata K, Vigneswaran W T., Alex C G., Garrity E R. Cylex ImmuKnow assay levels are lower in lung transplant recipients with infection. J Heart Lung Transplant 2008 27 990-994
18. Huang Y, Nizami Nazih Zuhdi I. Correlation of Cylex ImmuKnow assay with lung allograft biopsy [abstract]. J Heart Lung Transplant 2007 26 S175
19. Yousem S A., Martin T, Paradis I L., Keenan R, Griffith B P. Can immunohistological analysis of transbronchial biopsy specimens predict responder status in early acute rejection of lung allografts? Hum Pathol 1994 25 525-529
20. Reams B D., Musselwhite L W., Zaas D W. et al. Alemtuzumab in the treatment of refractory acute rejection and bronchiolitis obliterans syndrome after human lung transplantation. Am J Transplant 2007 7 2802-2808
21. Colombat M, Groussard O, Lautrette A et al. Analysis of the different histologic lesions observed in transbronchial biopsy for the diagnosis of acute rejection: clinicopathologic correlations during the first 6 months after lung transplantation. Hum Pathol 2005 36 387-394
22. Chakinala M M., Ritter J, Gage B F. et al. Reliability for grading acute rejection and airway inflammation after lung transplantation. J Heart Lung Transplant 2005 24 652-657
23. Stephenson A, Flint J, English J et al. Interpretation of transbronchial lung biopsies from lung transplant recipients: inter- and intraobserver agreement. Can Respir J 2005 12 75-77
24. Burton C M., Iversen M, Scheike T, Carlsen J, Andersen C B. Minimal acute cellular rejection remains prevalent up to 2 years after lung transplantation: a retrospective analysis of 2697 transbronchial biopsies. Transplantation 2008 85 547-553
25. DeVito Dabbs A, Hoffman L A., Iacono A T. et al. Pattern and predictors of early rejection after lung transplantation. Am J Crit Care 2003 12 497-507
26. Hachem R R., Khalifah A P., Chakinala M M. et al. The significance of a single episode of minimal acute rejection after lung transplantation. Transplantation 2005 80 1406-1413
27. Kim D W., Dacic S, Iacono A, Grgurich W, Yousem S A. Significance of a solitary perivascular mononuclear infiltrate in lung allograft recipients with mild acute cellular rejection. J Heart Lung Transplant 2005 24 152-155
28. Glanville A R., Aboyoun C L., Havryk A, Plit M, Rainer S, Malouf M A. Severity of lymphocytic bronchiolitis predicts long-term outcome after lung transplantation. Am J Respir Crit Care Med 2008 177 1033-1040
29. Scholma J, Slebos D J., Boezen H M. et al. Eosinophilic granulocytes and interleukin-6 level in bronchoalveolar lavage fluid are associated with the development of obliterative bronchiolitis after lung transplantation. Am J Respir Crit Care Med 2000 162 2221-2225
30. Schulman L L., Weinberg A D., McGregor C, Galantowicz M E., Suciu-Foca N M., Itescu S. Mismatches at the HLA-DR and HLA-B loci are risk factors for acute rejection after lung transplantation. Am J Respir Crit Care Med 1998 157 (6 Pt 1) 1833-1837
31. Quantz M A., Bennett L E., Meyer D M., Novick R J. Does human leukocyte antigen matching influence the outcome of lung transplantation? An analysis of 3,549 lung transplantations. J Heart Lung Transplant 2000 19 473-479
32. Treede H, Klepetko W, Reichenspurner H et al, Munich and Vienna Lung Transplant Group. Tacrolimus versus cyclosporine after lung transplantation: a prospective, open, randomized two-center trial comparing two different immunosuppressive protocols. J Heart Lung Transplant 2001 20 511-517
33. Hachem R R., Yusen R D., Chakinala M M. et al. A randomized controlled trial of tacrolimus versus cyclosporine after lung transplantation. J Heart Lung Transplant 2007 26 1012-1018
34. Kumar D, Erdman D, Keshavjee S et al. Clinical impact of community-acquired respiratory viruses on bronchiolitis obliterans after lung transplant. Am J Transplant 2005 5 2031-2036
35. Garantziotis S, Howell D N., McAdams H P., Davis R D., Henshaw N G., Palmer S M. Influenza pneumonia in lung transplant recipients: clinical features and association with bronchiolitis obliterans syndrome. Chest 2001 119 1277-1280
36. Zheng H X., Burckart G J., McCurry K et al. Interleukin-10 production genotype protects against acute persistent rejection after lung transplantation. J Heart Lung Transplant 2004 23 541-546
37. Zheng H X., Zeevi A, McCurry K et al. The impact of pharmacogenomic factors on acute persistent rejection in adult lung transplant patients. Transpl Immunol 2005 14 37-42
38. Palmer S M., Burch L H., Trindade A J. et al. Innate immunity influences long-term outcomes after human lung transplant. Am J Respir Crit Care Med 2005 171 780-785
39. Palmer S M., Klimecki W, Yu L et al. Genetic regulation of rejection and survival following human lung transplantation by the innate immune receptor CD14. Am J Transplant 2007 7 693-699
40. Ibrahim J E., Sweet S C., Flippin M et al. Rejection is reduced in thoracic organ recipients when transplanted in the first year of life. J Heart Lung Transplant 2002 21 311-318
41. Scott J P., Whitehead B, de Leval M et al. Paediatric incidence of acute rejection and obliterative bronchiolitis: a comparison with adults. Transpl Int 1994 7 (Suppl 1) S404-S406
42. Mahidhara R, Bastani S, Ross D J. et al. Lung transplantation in older patients? J Thorac Cardiovasc Surg 2008 135 412-420
43. Ruiz R, Kunitake H, Wilkinson A H. et al. Long-term analysis of combined liver and kidney transplantation at a single center. Arch Surg 2006 141 735-741 discussion 741-742
44. Pinderski L J., Kirklin J K., McGiffin D et al. Multi-organ transplantation: is there a protective effect against acute and chronic rejection? J Heart Lung Transplant 2005 24 1828-1833
45. Keenan R J., Bruzzone P, Paradis I L. et al. Similarity of pulmonary rejection patterns among heart-lung and double-lung transplant recipients. Transplantation 1991 51 176-180
46. Lau C L., Palmer S M., D'Amico T A., Tapson V F., Davis R D. Lung transplantation at Duke University Medical Center. Clin Transpl 1998 327-340
47. Vitulo P, Oggionni T, Cascina A et al. Efficacy of tacrolimus rescue therapy in refractory acute rejection after lung transplantation. J Heart Lung Transplant 2002 21 435-439
48. Sarahrudi K, Estenne M, Corris P et al. International experience with conversion from cyclosporine to tacrolimus for acute and chronic lung allograft rejection. J Thorac Cardiovasc Surg 2004 127 1126-1132
49. Shennib H, Massard G, Reynaud M, Noirclerc M. Efficacy of OKT3 therapy for acute rejection in isolated lung transplantation. J Heart Lung Transplant 1994 13 514-519
50. Keenan R J., Iacono A, Dauber J H. et al. Treatment of refractory acute allograft rejection with aerosolized cyclosporine in lung transplant recipients. J Thorac Cardiovasc Surg 1997 113 335-340 discussion 340-341
51. Dall'Amico R, Murer L. Extracorporeal photochemotherapy: a new therapeutic approach for allograft rejection. Transfus Apher Sci 2002 26 197-204
52. Valentine V G., Robbins R C., Wehner J H., Patel H R., Berry G J., Theodore J. Total lymphoid irradiation for refractory acute rejection in heart-lung and lung allografts. Chest 1996 109 1184-1189
53. Appel J Z. III, Hartwig M G., Davis R D., Reinsmoen N L. Utility of peritransplant and rescue intravenous immunoglobulin and extracorporeal immunoadsorption in lung transplant recipients sensitized to HLA antigens. Hum Immunol 2005 66 378-386
54. Appel J Z. III, Hartwig M G., Cantu E III, Palmer S M., Reinsmoen N L., Davis R D. Role of flow cytometry to define unacceptable HLA antigens in lung transplant recipients with HLA-specific antibodies. Transplantation 2006 81 1049-1057
55. Taylor C J., Smith S I., Morgan C H. et al. Selective omission of the donor cross-match before renal transplantation: efficacy, safety and effects on cold storage time. Transplantation 2000 69 719-723
56. Girnita A L., McCurry K R., Iacono A T. et al. HLA-specific antibodies are associated with high-grade and persistent-recurrent lung allograft acute rejection. J Heart Lung Transplant 2004 23 1135-1141
57. Palmer S M., Davis R D., Hadjiliadis D et al. Development of an antibody specific to major histocompatibility antigens detectable by flow cytometry after lung transplant is associated with bronchiolitis obliterans syndrome. Transplantation 2002 74 799-804
58. Hadjiliadis D, Chaparro C, Reinsmoen N L. et al. Pre-transplant panel reactive antibody in lung transplant recipients is associated with significantly worse post-transplant survival in a multicenter study. J Heart Lung Transplant 2005 24 (7, Suppl) S249-S254
59. Burlingham W J., Love R B., Jankowska-Gan E et al. IL-17-dependent cellular immunity to collagen type V predisposes to obliterative bronchiolitis in human lung transplants. J Clin Invest 2007 117 3498-3506
60. Goers T A., Ramachandran S, Aloush A, Trulock E, Patterson G A., Mohanakumar T. De novo production of K-alpha1 tubulin-specific antibodies: role in chronic lung allograft rejection. J Immunol 2008 180 4487-4494
61. Magro C M., Klinger D M., Adams P W. et al. Evidence that humoral allograft rejection in lung transplant patients is not histocompatibility antigen-related. Am J Transplant 2003 3 1264-1272
62. Badesch D B., Zamora M, Fullerton D et al. Pulmonary capillaritis: a possible histologic form of acute pulmonary allograft rejection. J Heart Lung Transplant 1998 17 415-422
63. Ionescu D N., Girnita A L., Zeevi A et al. C4d deposition in lung allografts is associated with circulating anti-HLA alloantibody. Transpl Immunol 2005 15 63-68
64. Miller G G., Destarac L, Zeevi A et al. Acute humoral rejection of human lung allografts and elevation of C4d in bronchoalveolar lavage fluid. Am J Transplant 2004 4 1323-1330
65. Magro C M., Abbas A E., Seilstad K, Pope-Harman A L., Nadasdy T, Ross P Jr. C3d and the septal microvasculature as a predictor of chronic lung allograft dysfunction. Hum Immunol 2006 67 274-283
66. Westall G P., Snell G I., McLean C, Kotsimbos T, Williams T, Magro C. C3d and C4d deposition early after lung transplantation. J Heart Lung Transplant 2008 27 722-728
67. Wallace W D., Reed E F., Ross D, Lassman C R., Fishbein M C. C4d staining of pulmonary allograft biopsies: an immunoperoxidase study. J Heart Lung Transplant 2005 24 1565-1570
68. Astor T L., Weill D, Cool C, Teitelbaum I, Schwarz M I., Zamora M R. Pulmonary capillaritis in lung transplant recipients: treatment and effect on allograft function. J Heart Lung Transplant 2005 24 2091-2097
69. Vo A A., Lukovsky M, Toyoda M et al. Rituximab and intravenous immune globulin for desensitization during renal transplantation. N Engl J Med 2008 359 242-251